Hemispherx Biopharma, Inc. (NYSE: HEB) is trading up 8% after the company presented a summary of the results of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE